返回
T
Thermo Fisher Scientific
学者数4.0K
论文数2.5K
被引数34
关联论文 (2268)
发表时间
Transportability of tislelizumab trial outcomes from RATIONALE-315, RATIONALE-303, and RATIONALE-312 to the European population in early-stage non-small cell lung cancer (NSCLC), advanced NSCLC and extensive-stage small cell lung cancer (ES-SCLC)RATIONALE-315、RATIONALE-303和RATIONALE-312试验中替雷利珠单抗在早期非小细胞肺癌(NSCLC)、晚期NSCLC和广泛期小细胞肺癌(ES-SCLC)中试验结果的欧洲人群适用性
Future Oncology
IF2.6

